As part of our cancer treatments, we include Intravenous Curcumin therapy in most of our adjunctive therapeutic plans.
Intravenous Curcumin refers to the method of administering Curcumin parenterally (i.e. to bypass the gut and liver), in order to achieve therapeutic levels in the blood, tissues, and organs. Let us explain how and why we offer IV Curcumin in our clinic.
How does Curcumin affect cancer cells?
- Curcumin has a capability to inhibit carcinogen bioactivation via suppression of specific cytochrome P450 isozymes, as well as to induce the activity or expression of phase II carcinogen-detoxifying enzymes.
- It’s a strong detoxifying and antioxidizing agent through various mechanisms.
- It decreases inflammation and interferes with cell growth by inhibition of protein kinases.
- Curcumin is a highly pleiotropic molecule found in the rhizomes of Curcuma longa (turmeric). It is responsible for the yellow color of turmeric and has been shown to inhibit the proliferation of cancer cells and to be of use in preventing or treating a number of diseases. 
Curcumin is one of the most promising phytochemicals that target various cancers and inflammation-mediated diseases. 
Why do patients choose Curcumin?
It may be given by intravenous (IV) infusion – through a vein into the bloodstream. When taken by intravenous infusion, Curcumin can reach much higher levels in the blood than when the same amount is taken orally.
It improves the quality of life in general, by positively influencing the physical, mental and emotional functions as well as relieving such symptoms as fatigue, nausea and vomiting, pain, and loss of appetite.
Curcumin treatment targets shows that it potently acts on major intracellular components involved in key processes such as genomic modulations, cell invasion and cell death pathways. 
IV Curcumin treatment has been shown to modulate multiple cell-signaling pathways simultaneously, thereby mitigating or preventing many different types of cancers, including multiple myeloma and colorectal, pancreatic, breast, prostate, lung, head, and neck cancers.